Featured Session: Psychedelics for Therapeutics and Well-being

Recording: Featured Session: Psychedelics for Therapeutics and Well-being, Date TBA

Modern research on psychedelics is turning the “turn-on, tune-in, and drop-out” culture of the 1960’s upside down. What was once considered a recreational activity is now an evidence-based treatment for psychiatric disease. But how can psychedelics be widely used to alleviate human suffering through clinician-guided treatment of illnesses such as depression, PTSD, and addiction? Do mystical-type and insightful-type experiences associated with these substances improve overall well-being in patients and in healthy individuals? How can investors make psychedelic medicine accessible by financing academic research and for-profit companies and clinics? What is next for the 21st century renaissance of psychedelic medicine as it becomes an established treatment and wellness aid? Learn more in this panel discussion organized by the New York Academy of Sciences for SXSW 2022.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

Roland Griffiths

Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine

John Krystal, MD

Yale University

This event will be live

This event will be available online

This event will be in person

This event will be available on demand on Monday, March 21st 2022 at 10:00am CT

This event will be available in American Sign Language

This event will be available with closed captioning


Primary Entry:
Music Badge
Platinum Badge
Film Badge
Interactive Badge
SXSW Online

Featured Session




Health & MedTech track sponsored by Optum


The State of Psychedelics summit sponsored by Vine VC